Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 19, 2025 • 12:31 PM ET

Date/Time Source News Release
05/08/2025 06:59 AM EDT PR Newswire Q32 Bio Reports First Quarter 2025 Financial Results and Provides Corporate Update
04/30/2025 06:59 AM EDT PR Newswire Q32 Bio Announces FDA Fast Track Designation Granted to Bempikibart (ADX-914) for the Treatment of Alopecia Areata
04/16/2025 06:59 AM EDT PR Newswire Q32 Bio Doses First Patients in Both Part A Open-Label Extension and Part B of SIGNAL-AA Phase 2a Trial Evaluating Bempikibart in Alopecia Areata
03/11/2025 06:59 AM EDT PR Newswire Q32 Bio Reports Fourth Quarter 2024 Financial Results and Provides Corporate Update
03/08/2025 11:00 AM EST PR Newswire Q32 Bio Presents Results from SIGNAL-AA Part A Clinical Trial Evaluating Bempikibart in Patients with Alopecia Areata at the 2025 American Academy of Dermatology Meeting
02/28/2025 09:00 AM EST PR Newswire Q32 Bio Announces Late-Breaking Presentation of Results from SIGNAL-AA Part A Clinical Trial of Bempikibart in Alopecia Areata at the 2025 American Academy of Dermatology Annual Meeting
02/26/2025 06:59 AM EST PR Newswire Q32 Bio to Participate in Upcoming March Investor Conferences
02/10/2025 04:05 PM EST PR Newswire Q32 Bio Announces Strategic Restructuring to Focus on Advancement of Bempikibart in Patients with Alopecia Areata
02/04/2025 04:05 PM EST PR Newswire Q32 Bio to Participate in Oppenheimer's 35th Annual Healthcare Life Sciences Conference
12/10/2024 04:05 PM EST PR Newswire Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program
Page
  • 1
  • 2

Additional News

As of June 19, 2025 • 12:31 PM ET

Date/Time Source News Release
05/08/2025 10:04 AM EDT SeekingAlpha Q32 Bio GAAP EPS of -$0.90
05/08/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 8th, 2025
05/08/2025 05:31 AM EDT US Earnings Reports Expected earnings - Q32 Bio Inc.
04/08/2025 12:00 PM EDT Zacks All You Need to Know About Q32 Bio (QTTB) Rating Upgrade to Buy
03/11/2025 07:24 AM EDT SeekingAlpha Q32 Bio GAAP EPS of -$1.16 beats by $0.37
03/11/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, March 11th, 2025
03/11/2025 05:31 AM EDT US Earnings Reports Expected earnings - Q32 Bio Inc.
02/12/2025 10:36 AM EST SeekingAlpha Q32 downgraded to market perform by BMO over ADX-097
02/11/2025 11:51 AM EST SeekingAlpha Q32 cut to neutral by Piper on ADX-097 discontinuation
01/07/2025 12:00 PM EST Zacks Q32 Bio (QTTB) Upgraded to Buy: What Does It Mean for the Stock?
Page
  • 1
  • 2

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.